A LinkedIn post from Pear VC highlights a new episode of its Pear Healthcare Playbook series focused on AI in patient access. The episode features Assort Health Co‑founder and Co‑CEO Jeffery L. in conversation with Anson Zhou and Andrew Parambath, M.D., MBA, on how AI voice agents may change how patients connect with care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, the discussion covers the early stages of building Assort Health, the process of achieving initial real‑world deployments, and the strategic importance of specialty‑specific AI in healthcare workflows. The conversation also explores a long‑term vision for AI‑powered patient access, suggesting a thesis that automation at the front door of care could reduce friction and operating costs for providers.
For investors, the post points to Pear VC’s continued focus on AI‑enabled healthcare infrastructure rather than purely consumer-facing health apps. Emphasis on specialty‑specific AI and live deployments implies that portfolio companies in Pear’s orbit may be targeting higher‑value, workflow‑embedded use cases that can command enterprise budgets and stickier contracts.
If AI voice agents prove effective in reducing wait times and call-center burdens, this approach could open sizeable markets in revenue-cycle support, patient scheduling, and triage for health systems. Pear VC’s attention to this niche may indicate where it sees defensible differentiation and scalable returns in the broader digital health and healthcare AI landscape.